Skip to Main Content
Martin Thelin

Martin Thelin

MD

Pediatric endocrinologist

Dr. Martin Thelin is a pediatric endocrinologist who cares for children and adolescents with cholesterol and triglyceride disorders. He leads the Pediatric Lipid Clinic at UCSF, providing comprehensive evaluation and management of lipid disorders (abnormal fat and cholesterol levels in the blood) in young patients. His goal is to prevent early-onset cardiovascular disease by diagnosing lipid abnormalities early and tailoring therapies — including lifestyle coaching, family-centered education and new medications — to each child's needs.

In research, Thelin is interested in how inflammation, autoimmunity and metabolic dysfunction in childhood are linked to faulty lipid metabolism (the formation and breakdown of lipids), with a particular focus on the connection between lipid disorders and immune dysregulation. Working closely with families, clinical teams and laboratory scientists, he aims to advance innovative therapies for children with high-risk or genetic lipid abnormalities.

Thelin earned his medical degree and doctorate in biochemistry from Lund University in Sweden. He completed a residency in pediatrics and a fellowship in pediatric endocrinology at UCSF. He also completed postdoctoral training in immunology and type 1 diabetes at the Joslin Diabetes Center, an affiliate of Harvard Medical School.

  • Board Certifications

    American Board of Pediatrics, Pediatrics

    American Board of Pediatrics, Endocrinology and Metabolism

  • Fellowships

    UCSF Graduate Medical Education, Pediatric Endocrinology

  • Residencies

    UCSF Graduate Medical Education, Pediatrics

  • Degree

    MD, Lund University

  • Languages

    Swedish

Where I see patients (2)

    Decorative Caduceus

    Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous F...

    Evaluate the effect of inclisiran compared to placebo on reducing LDL-C [percent change] at Day 330

    Recruiting

    More about this study
    Decorative Caduceus

    Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hype...

    Demonstrate superiority of inclisiran compared to placebo in reducing LDL-C [percent change] at Day 330

    Recruiting

    More about this study
    See all clinical trials

    Learning never stops

    Our classroom and bedside classes help kids get credit and keep learning during treatment.

    See our school program

    Share